medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 1

<< Back Next >>

Acta Med 2004; 2 (1)

Does a sentinel node exists in patients with upper aero-digestive tract epidermoid carcinoma (UADTEC)?

Gallegos HJF, Pichardo RP
Full text How to cite this article

Language: Spanish
References: 17
Page: 13-17
PDF size: 62.24 Kb.


Key words:

Lymphatic mapping, sentinel node, tongue cancer, UADT.

ABSTRACT

Introduction: Standard neck treatment in patients with upper aero-digestive tract epidermoid carcinoma (UADTEC) without palpable cervical nodes (cN0) is elective-selective neck dissection (ND); nevertheless, in patients without metastasis in the dissection specimen (pN0) ND has no impact on regional control. Approximately 70% of cN0 patients are pN0 and are exposed to morbidity; in these patients, lymphatic mapping and sentinel node biopsy (LMSNB) could be an alternative for neck staging. The objective of this study was to know the feasibility of LMSNB technique performed with blue dye and Rhenium colloid in UADTEC patients. Methods: The day prior to surgery, 3mCi of Rhenium colloid were injected peritumorally (p.t.) into 15 patients with T1-2, N0, and lymphogammagraphy of >4-mm thickness of oral tongue was done immediately at 1 and 2 h after injection; site of sentinel node (SN) was identified in neck skin with ink. Twenty min prior to surgery, 1 mL of blue patent V was injected into the same site. Neoprobe 2000TM was used to identify the hot spot during surgery. All hot and/or blue nodes were considered SN and studied by frozen section. All patients were submitted to supra-omohioid neck dissection Results: Lymphogammagraphy showed at least 1 SN in all 15 patients. In two patients, SN was identified at stage IV. ed to measure attitudes toward the entire process. Validation of the attitude survey may become a valuable source of information for detecting opportunities in this field. During surgery, at least 1 SN was identified in all patients (success index = 100%), 3/15 patients showed metastasis in GC, and none of the 12 patients with negative SN had metastasis in non-sentinel nodes (no false negatives). Conclusions: It is possible to identify SN in patients with UADT carcinoma; SN predicts non-sentinel nodes status in neck.


REFERENCES

  1. Shah JP, Lydiatt WM. Buccal mucosa, alveolus retromolar trigone, floor of the mouth, hard palate and tongue tumors. In: Thawlew SE, Panje WR, Batsakis JG, Lindberg RD. editores. Comprehensive management of head and neck tumors. Philadelphia, PA, USA: WB. Saunders Co.; 1999. 686-694.

  2. Boyle JO, Strong EW. Oral cavity cancer. In: Shah JP. Cancer of the head and neck. BC Decker editores. 2001. Hamilton.100-126

  3. Gallegos Hernández JF, Hernández Hernández DM, Arias Ceballos H. Elective neck dissection in tongue cancer patients. Oncología (submitted).

  4. Andersen PE, Saffold S. Management of cervical metastasis. In: Shah JP. Cancer of the head and neck. BC Decker. Editores; 2001. Hamilton. 274-287.

  5. Vandenbrouck C, Sancho Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity. Cancer 1980; 46: 386-390.

  6. Gallegos Hernández JF, Martínez-Gómez H, Flores-Díaz R. The radical neck dissection in upper aero-digestive tract cancer. Indications, extension and radicality. Cir Ciruj 2002; 70: 369-376.

  7. Gallegos Hernández JF, Gutiérrez F, Barroso S, Labastida S y Reséndiz J. Identificación del ganglio centinela con azul patente V en pacientes con melanoma cutáneo. Gac Med Mex 1998; 134(4): 285-288.

  8. Gallegos-Hernández JF, Nieweg OE, Tanis P, Valdés-Olmos RA, Rutgers EH, Kroon BB. La biopsia del ganglio centinela en melanoma no es aún el tratamiento estándar. Gac Med Mex 2003; 139(6): 205-208.

  9. Gallegos-Hernández JF, Chávez-García MA. Utilidad del mapeo linfático con inyección subareolar de colorante azul patente, en la etapificación del cáncer de mama. Rev Invest Clin 2003; 55: 407-411.

  10. Gallegos-Hernández JF. Linfadenectomía selectiva del ganglio centinela en pacientes con cáncer de mama. Una alternativa a la disección radical de axila. Acta Med Gpo Ang 2003; 1(3): 127-131.

  11. Fleming FJ, Kavanaugh D, Crotty TB y cols. Factors affecting to non sentinel-nodes in breast cancer. J Clin Pathol 2004; 57:73-76.

  12. van Iterson V, Leidenius M, Krogerus L, von Smiten K. Predictive factors for the status non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 2003; 82: 39-45.

  13. Ross G, Shoaib T, Soutar DS et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2003; 128: 1287-1291.

  14. Werner JA, Düne AA, Myers JN. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head & Neck 2003; 25: 322-332.

  15. Mamelle G. Selective neck dissection and sentinel node biopsy in head and neck squamous cell carcinomas. Recent Results Cancer Res 2000; 157: 193-200.

  16. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.

  17. Nieweg OE, Jansen L, Valdés-Olmos RA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999; 26(suppl): S11-S116.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2004;2